CDER Compounding Oversight Challenge Forces Axelrad To Narrow Her Focus
This article was originally published in The Pink Sheet Daily
Executive Summary
The long-time head of CDER’s Office of Regulatory Policy will become senior advisor to center Director Janet Woodcock in charge of pharmacy compounding issues effective Jan. 6.
You may also be interested in...
CDER Begins Search for New Regulatory Policy Chief
Search for permanent director for the Office of Regulatory Policy comes after several leadership departures in the last year.
CDER’s New Compliance Director Sklamberg Brings Experience On Compounding Issues
Howard Sklamberg, deputy associate commissioner in FDA’s Office of Regulatory Affairs, will take over as director of the Center for Drug Evaluation and Research’s Compliance Office in January; acting compliance director Ilisa Bernstein will resume her role as deputy director.
FDA’s Compounding Oversight: What Price Safety?
As meningitis outbreak widens, FDA and members of Congress are calling for clarification of what jurisdiction the agency has over pharmacies, but agency officials are stopping short of asking for clear new authorities.